Comorbid anxiety disorders compound challenges associated with bipolar disorder treatment.
A pair of phase 3 studies recently demonstrated that Teva Pharmaceutical Industries’ investigational treatment for moderate-to-severe asthma in patients with elevated blood eosinophils reduces asthma exacerbation rates by at least half.
Almost all women and seniors with atrial fibrillation should be receiving blood thinners, advises a new analysis of updated clinical practice guidelines.
Antibiotic prescribing rates tend to rise when retail clinics and physician offices compete for patients in affluent areas with abundant access to health care professionals.
Casting doubt on previous conjectures, a new study suggests that statins do not protect patients against Parkinson’s disease.
Teva Pharmaceutical Industries’ investigational drug designed to prevent chronic migraines recently demonstrated positive results in a phase 2 study.
An OTC allergy medication may be able to kill the bacteria behind Lyme disease, bringing researchers closer to developing the first targeted therapy for the debilitating infection.
Fed up with alleged unpaid overtime and missed rest periods, a Walmart pharmacist is fighting back against the retail giant with a class action suit.
Preventing exposures to blood and body fluids is critical to preventing occupationally acquired HIV.
If you suffer from migraines, you are not alone.
Various treatments for osteoarthritis can decrease pain and maintain joint mobility.
With proper treatment, individuals with atrial fibrillation can live normal and active lives.
Sore throats lasting longer than a week require medical attention.
Strategic Alliance Partners
Directions in Pharmacy
Specialty Pharmacy Times